833 CRB-601, a selective integrin αvβ8-blocking antibody, prevents TGFβ activation, promotes immune cell remodeling, and exhibits potent antitumor activity
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Jezik: | English |
| Izdano: |
BMJ Publishing Group
2023-11-01
|
| Serija: | Journal for ImmunoTherapy of Cancer |